Nanotechnology In Cancer Treatment Market Is Predicted To Reach $319.04 Billion, Expanding At 14.9% CAGR Through 2030

 

What Are The Estimated Market Size And CAGR For The Nanotechnology In Cancer Treatment Market Between 2026 And 2030?
 The nanotechnology in cancer treatment market size has grown rapidly in recent years. It will grow from $159.07 billion in 2025 to $183.23 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing cancer incidence rates, advancements in nanomaterial engineering, expansion of oncology research funding, growing collaboration between pharma and research institutions, early clinical success of nano-based therapies.
 
 The nanotechnology in cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $319.04 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer treatment approaches, rising investments in nanomedicine research, expansion of clinical trials using nanotechnology, growing focus on minimally invasive cancer therapies, advancements in nano-enabled diagnostics. Major trends in the forecast period include increasing development of nanoparticle-based drug delivery systems, rising adoption of targeted cancer therapies, growing use of multifunctional nanomaterials, expansion of personalized oncology treatments, enhanced focus on reducing chemotherapy side effects.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=27357&type=smp
 
 Which Primary Market Drivers Are Fueling Momentum In The Nanotechnology In Cancer Treatment Market?
 The growing demand for targeted therapies is expected to propel the growth of nanotechnology in the cancer treatment market going forward. Targeted therapies refer to cancer treatments that specifically target molecular markers or pathways involved in tumor growth and progression. The rise in demand for targeted therapies is due to their ability to precisely attack cancer cells, reducing damage to healthy tissue and minimizing side effects. Nanotechnology in cancer treatment enhances targeted therapies by enabling precise delivery of drugs directly to cancer cells, improving effectiveness and minimizing harm to healthy tissues. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of Q1 2023, there were 247 gene therapies in Phase II, this number rose by 5% and reached 260 by the end of Q2 2023. Therefore, the growing demand for targeted therapies is driving the growth of nanotechnology in the cancer treatment market.
 
 What Major Market Segments Contribute To Shaping The Overall Framework Of The Nanotechnology In Cancer Treatment Market?
 The nanotechnology in cancer treatment market covered in this report is segmented — 
 
 1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles
 2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance
 3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types
 4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems
 5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)
 
 Subsegments:
 1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes
 2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers
 3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles
 
 Which Rising Trends Are Anticipated To Influence The Future Trajectory Of The Nanotechnology In Cancer Treatment Market?
 Major companies operating in the nanotechnology in cancer treatment market are focusing on developing advanced treatments such as immunotherapy nano formulation to enhance immune system targeting and minimize adverse effects in cancer patients. Immunotherapy nano formulation uses nanotechnology to deliver immune-based therapies directly to target sites, enhancing precision treatment while improving drug stability, bioavailability, and immune response activation. For instance, in December 2023, Cello Therapeutics, a US-based biotechnology company, launched CE120, a broad-spectrum therapeutic cancer nano vaccine that secured Food and Drug Administration clearance. This therapy marks the first clinical use of platelet membrane-coated nanoparticles for treating solid tumors. CE120 combines targeted drug delivery with immune system activation, aiming to destroy tumors and prevent recurrence. Its unique nanotechnology platform enhances both therapeutic precision and immune response. This milestone positions CE120 as a pioneering nanomedicine in cancer treatment.
 
 Who Are The Established And Emerging Players Expanding Their Footprint In The Nanotechnology In Cancer Treatment Market?
 Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., Selecta Biosciences Inc., Bind Therapeutics Inc., BlueWillow Biologics Inc., Nanobiomed Inc. 
 
 Get Your In-Depth Nanotechnology In Cancer Treatment Market Report Now:
 https://www.thebusinessresearchcompany.com/report/nanotechnology-in-cancer-treatment-global-market-report
 
 Which Regions Demonstrate The Highest Growth Momentum In The Nanotechnology In Cancer Treatment Market?
 North America was the largest region in the nanotechnology in cancer treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company